Improving Chronic Care Management | Hillrom

Skip to Content

case-study-page

knowledge

https://www.hillrom.com/en/products/promotions/improving-chronic-care/#overview-0

PHYSICAL EXAM TOOLS
https://www.hillrom.com/en/products/promotions/improving-chronic-care/#educationdocumentation-1

CARDIAC CARE
https://www.hillrom.com/en/products/promotions/improving-chronic-care/#technicalspecifications-2

PEDIATRIC VISION SCREENING
https://www.hillrom.com/en/products/promotions/improving-chronic-care/#configuration-3

HYPERTENSION MANAGEMENT
https://www.hillrom.com/en/products/promotions/improving-chronic-care/#partsaccessories-4

DIABETIC RETINAL EXAMS

PHYSICAL EXAM TOOLS

play_circle_outline

BIGGER, BRIGHTER VIEWS

Examining the structure of the eye and ear is a fleeting yet critical part of the physical exam. That’s why we’ve listened to countless providers and redesigned our otoscopes and ophthalmoscopes for enhanced exams. Let us change your view.

CARDIAC CARE

SIMPLIFY, SECURE AND CONNECT CARDIAC CARE

The Welch Allyn ELI 280 electrocardiograph provides comprehensive functionality in a portable touchscreen device. The easy-to-use device is designed to meet the demands of high-volume ECG environments

EXPERIENCE THE ELI 280
IN YOUR OWN SPACE

PEDIATRIC VISION SCREENING

A child sits on a mother’s lap while the clinician sits across from them completing a vision screening with the Welch Allyn® Spot® Vision Screener.

SIGHT-SAVING PEDIATRIC SCREENING

Vision disability is the single most prevalent disabling condition among children.¹ The AAP recommends instrument-based vision screening as early as 12 months of age, if available.² Yet, 70% of pediatricians are not doing automated vision screening.³

The Welch Allyn Spot Vision Screener can quickly and easily detect vision disorders in children to help improve sight and prevent blindness.

HYPERTENSION MANAGEMENT

PRECISE HYPERTENSION MANAGEMENT

Get a handle on hypertension with better blood pressure management with Welch Allyn smart solutions.

Better understand how to diagnose hypertension to help meet the challenge for your patients, your practice and your community.

EXPLORE OUR SOLUTIONS

A clinician fastens a blood pressure cuff to a patient’s arm with the Welch Allyn® Spot® Vital Signs device in the background.

DIABETIC RETINAL EXAMS

CLOSING THE DIABETIC RETINAL EXAM CARE GAP

Up to 80% of individuals with diabetes will eventually develop some stage of diabetic retinopathy.⁴ With early detection, up to 95% of vision loss from diabetic retinopathy—the leading cause of blindness for working-age adults⁵—is preventable.⁶ The Welch Allyn RetinaVue care delivery model makes diabetic retinal exams simple and affordable for community health centers.

REQUEST A VIRTUAL DEMO

Hillrom and Welch Allyn—Improving Chronic Care Management Together

You're on the front line of population health.

In a complex healthcare system, community health centers represent the first line of defense against the health issues patients face today. Effectively managing chronic conditions and identifying risk factors early can help you achieve better outcomes at a lower cost while improving both the clinician and patient experience.

At Hillrom, we give you smart tools to help you identify, diagnose and manage the prevalent health issues you see every day.

Ready to Speak with a Representative?

Let’s Connect

Fill out the form below to connect with a representative and learn more about how Hillrom can help you maximize care with the right solutions for your patients.

References

Centers for Disease Control and Prevention: Fast Facts of Common Eye Disorders. https://www.cdc.gov/visionhealth/basics/ced/fastfacts.htm
Wyckoff, Alyson Sulaski, and Associate Editor. “New Reports Shine Light on Vision Screening for Primary Care Offices,” December 7, 2015. https://publications.aap.org/aapnews/news/12308/New-reports-shine-light-on-vision-screening-for.
Welch Allyn Market Research 2016
Duration of diabetes is a major risk factor associated with the development of diabetic retinopathy. After five years, approximately 25% of type 1 patients will have retinopathy, increasing to 80% after 15 years. For type 2 patients, the risk of developing retinopathy is 84% and 53% after 19 years for those taking or not taking insulin, respectively. Diabetic Retinopathy Preferred Practice Pattern® from the American Academy of Ophthalmology, http://dx.doi.org/10.1016/j.ophtha.2019.09.025, ISSN 0161-6420/19. Accessed July 29, 2020.
Centers for Disease Control and Prevention. Vision Health Initiative (VHI). https://www.cdc.gov/visionhealth/basics/ced/ Published September 29, 2015.
National Eye Institute. People With Diabetes Can Prevent Vision Loss. https://www.nei.nih.gov/sites/default/files/2019-06/diabetes-prevent-vision-loss.pdf